期刊文献+

盐霉素诱导的细胞自噬机制在抗癌治疗中的应用进展 被引量:3

Progress and application of salinomycin-induced cell autophagy in anti-cancer treatment
下载PDF
导出
摘要 自噬在肿瘤的发生、发展、治疗过程中扮演着重要的角色。盐霉素作为一种聚醚类离子载体型抗生素,一直被用于防治鸡球虫病和促进反刍动物生长;它也能有效杀伤多种肿瘤干细胞及多药耐药肿瘤细胞系,且在此过程中伴随自噬的发生。盐霉素诱导的自噬是复杂的,可由细胞内活性氧升高而激活自噬;可通过损伤线粒体引发线粒体自噬;可引起内质网应激,通过AKT1-mTOR信号通路激活自噬。此外,盐霉素可抑制自噬潮的晚期阶段,有助于肿瘤微环境的破坏和自身抗肿瘤作用的提高。本文综述了盐霉素在禽畜疾病中的应用及机制、盐霉素抗肿瘤的作用机制及盐霉素诱导自噬的机制。 Summary Autophagy is a cell self-eating process that allows the orderly degradation and recycling of misfolded proteins and damaged organelles through lysosome.It plays a vital role in cells”adaptation to metabolic stress and homeostasis as well as the formation,development and treatment of tumors.Autophagy is a double-edged sword, both suppressing and facilitating tumorigenesis.For example,multiple benign tumors formed in the liver when autophagy gene Atg5 was mosaically deleted in mice.But at the same time,cancer cells can upregulate autophagy to survive under microenvironmental stress, promote tumor dormancy and increase their growth and aggressiveness. Salinomycin is a polyether ionophore antibiotic isolated from Streptomycesalbus.Compared with lasalocid and monensin,salinomycin is less toxic,lower priced and less susceptible to drug resistance,which enables worldwide use to prevent chicken coccidiosis and promote the growth of ruminants.As an antimicrobial drug,salinomycin acts as an ionophore for K+ and Na+ ions and is able to alter cytoplasmic and mitochondrial membrane potentials, thereby inhibiting oxidative phosphorylation.Besides,salinomycin can activate a MutS homolog 1-dependent cell cycle checkpoint,leading to the ultimate death of the coccidial parasites. In 2009,salinomycin was reported to exert a powerful effect on breast cancer stem cells (CSCs),and itnbsp;reduced the proportion of CSCs by more than 100 folds relative to paclitaxel.Up to now,it has been shown that salinomycin could effectively kill a variety of CSCs and multi-drug resistant cell lines by inhibiting Wnt/β-catenin signaling pathways, curbing cell cycle progression and reversing epithelial-mesenchymal transformation. Anticarcinogen can directly trigger apoptosis,autophagy and necrosis simultaneously.Most of cancer cell lines utilize autophagy to protect themselves from death after treatment with salinomycin. However, inhibiting autophagy through siRNA or PI3K inhibitor partially prevents cell death upon the addition of salinomycin in SW620 cells,indicating that autophagy induced by salinomycin can provoke cell death.The process of autophagy induced by salinomycin is complicated.Salinomycin can activate autophagy through different ways:1) increasing intracellular reactive oxygen species (ROS),partly via ROS-JNK/AMPK signaling pathways;2) triggering mitophagy by damaging mitochondria;3) inducing endoplasmic reticulum stress to activate autophagy via AKT1-mTOR signaling pathway. In addition, salinomycin does not interfere with the autophagosome-lysosome fusion except suppressing autophagic flux at the late stage by diminishing the lysosome activity.Poor microenvironmental conditions,such as hypoxia,elevated interstitial fluid pressure,glycolysis,low pH and inflammatory cell infiltration,are common features of solid tumors,which are closely related to tumor progression,metastasis and therapy.Salinomycin significantly reduces F4/80+ and CD11B+ inflammatory cells of the tumor microenvironment in mice with pulmonary metastasis.Hypoxia,the focus of most studies,is involved in tumor angiogenesis and the generation and maintenance of CSCs.Low pH has a great influence on drug metabolism,rendering multi-drug resistant of the cancer cells.Autophagy is always upregulated in hypoxic and low pH regions of tumors for the metabolic adaptation of cancer cells.The efficiency of hydroxychloroquine,a late-stage autophagy inhibitor by disrupting lysosome acidification under clinical investigation,is strongly impaired in acidic tumor environments due to drug resistance.However,according to a new study,salinomycin could effectively inhibit autophagy flux under conditions of transient and chronic acidosis.This contributed to the elimination of several cancer cell lines and enhanced cytotoxic effects of salinomycin on CSCs.In short,the inhibition of autophagy flux by salinomycin leads to a considerable change in the tumor microenvironment,which makes salinomycin more potent in terms of the antitumor ability and provides new insights into drug combination. In sum, this paper reviews the antitumor mechanism and application of salinomycin in livestock, the relationship between autophagy and tumor,and the mechanism of autophagy induced by salinomycin.
出处 《浙江大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2016年第6期694-702,共9页 Journal of Zhejiang University:Agriculture and Life Sciences
基金 国家自然科学基金(81172560,81400511) 浙江省自然科学基金(Y14H140014)
关键词 盐霉素 肿瘤 自噬 凋亡 球虫病 salinomycin tumor autophagy apoptosis coccidiosis
  • 相关文献

参考文献1

二级参考文献76

  • 1Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma.Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1].
  • 2El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683].
  • 3Llovet JM, Bruix J. Molecular targeted therapies in hepatocellularcarcinoma. Hepatology 2008; 48: 1312-1327 [PMID: 18821591DOI: 10.1002/hep.22506].
  • 4Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF,de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, PortaC, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, BorbathI, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D,Bruix J. Sorafenib in advanced hepatocellular carcinoma. N EnglJ Med 2008; 359: 378-390 [PMID: 18650514 DOI: 10.1056/NEJMoa0708857].
  • 5Kudo M. Current status of molecularly targeted therapy forhepatocellular carcinoma: clinical practice. Int J Clin Oncol 2010;15: 242-255 [PMID: 20509038 DOI: 10.1007/s10147-010-0089-y].
  • 6Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellulartumors. Oncogene 2006; 25: 3778-3786 [PMID: 16799619 DOI:10.1038/sj.onc.1209547].
  • 7Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liverregeneration and hepatocellular cancer: sorting the good from thebad. Semin Cancer Biol 2011; 21: 44-58 [PMID: 21182948 DOI:10.1016/j.semcancer.2010.12.010].
  • 8Clevers H, Nusse R. Wnt/兝-catenin signaling and disease. Cell 2012;149: 1192-1205 [PMID: 22682243 DOI: 10.1016/j.cell.2012.05.012].
  • 9Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling inhepatocellular carcinoma. Front Biosci 2006; 11: 1901-1915[PMID: 16368566].
  • 10Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wntsignaling in cancer. Biochim Biophys Acta 2003; 1653: 1-24 [PMID:12781368].

共引文献54

同被引文献33

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部